MXCT vs REG
MaxCyte Inc (MXCT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
REG does not have a complete income-statement cache yet.
MXCT currently screens at market cap $124.3M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the MXCT and REG stock pages for the full models.
Not investment advice.